MT HB794

Removes the utilization plan requirement for pharmacies and out-of-state mail order pharmacies, eliminating the need for Board approval of pharmacy technician supervision ratios

Requires pharmacists to obtain a formal endorsement from the Board of Pharmacy to practice as a clinical pharmacist practitioner, with ongoing requirements for maintaining a pharmacist license, additional education/certification, and a current collaborative pharmacy practice agreement

Eliminates the 5-business-day notification requirement for pharmacists to communicate biosimilar product substitutions to prescribers, and removes the requirement to post generic drug signage in pharmacies

Clarifies that wholesale distribution licenses apply to prescription devices in addition to prescription drugs, and updates terminology from "mail service pharmacy" to "mail order pharmacy" throughout the statutes

Repeals sections 37-7-307, 37-7-308, 37-7-309 (utilization plan provisions) and 37-7-506 (purchaser notice requirements for generic drug substitution)